Synthesis and anti-HBV activity of novel 3'-N-phenylsulfonyl docetaxel analogs. 2013

Jun Chang, and Yun-Peng Hao, and Xiao-Dong Hao, and Hong-Fu Lu, and Jian-Ming Yu, and Xun Sun
Department of Natural Products Chemistry, School of Pharmacy, Fudan University, Shanghai 201203, China.

Nine new 3'-N-phenylsulfonyl docetaxel analogs were synthesized in good yields from the key intermediate N-phenylsulfonyl oxazolidine via a six-step route. These analogs were tested for anti-hepatitis B virus (HBV) activity in vitro. Compounds 3e, 3g and 3j showed more potent inhibitory activity against HBeAg secretion than the positive control lamivudine. Further extensive SAR and mechanistic studies will be reported in due course.

UI MeSH Term Description Entries
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077143 Docetaxel A semisynthetic analog of PACLITAXEL used in the treatment of locally advanced or metastatic BREAST NEOPLASMS and NON-SMALL CELL LUNG CANCER. Docetaxel Anhydrous,Docetaxel Hydrate,Docetaxel Trihydrate,Docetaxol,N-Debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol,NSC 628503,RP 56976,RP-56976,Taxoltere Metro,Taxotere,N Debenzoyl N tert butoxycarbonyl 10 deacetyltaxol,RP56976
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013450 Sulfones Sulfone
D017239 Paclitaxel A cyclodecane isolated from the bark of the Pacific yew tree, TAXUS BREVIFOLIA. It stabilizes MICROTUBULES in their polymerized form leading to cell death. 7-epi-Taxol,Anzatax,Bris Taxol,NSC-125973,Onxol,Paclitaxel, (4 alpha)-Isomer,Paxene,Praxel,Taxol,Taxol A,7 epi Taxol,NSC 125973,NSC125973,Taxol, Bris
D043823 Taxoids A group of diterpenoid CYCLODECANES named for the taxanes that were discovered in the TAXUS tree. The action on MICROTUBULES has made some of them useful as ANTINEOPLASTIC AGENTS. Taxanes,Taxoid
D056945 Hep G2 Cells A human liver tumor cell line used to study a variety of liver-specific metabolic functions. Cell Line, Hep G2,Cell Line, Hepatoblastoma G2,Hep G2 Cell Line,HepG2 Cells,Hepatoblastoma G2 Cell Line,Cell, Hep G2,Cell, HepG2,Cells, Hep G2,Cells, HepG2,Hep G2 Cell,HepG2 Cell

Related Publications

Jun Chang, and Yun-Peng Hao, and Xiao-Dong Hao, and Hong-Fu Lu, and Jian-Ming Yu, and Xun Sun
March 1998, Bioorganic & medicinal chemistry letters,
Jun Chang, and Yun-Peng Hao, and Xiao-Dong Hao, and Hong-Fu Lu, and Jian-Ming Yu, and Xun Sun
August 2016, Bioorganic & medicinal chemistry letters,
Jun Chang, and Yun-Peng Hao, and Xiao-Dong Hao, and Hong-Fu Lu, and Jian-Ming Yu, and Xun Sun
December 2022, Bioorganic & medicinal chemistry letters,
Jun Chang, and Yun-Peng Hao, and Xiao-Dong Hao, and Hong-Fu Lu, and Jian-Ming Yu, and Xun Sun
July 2010, Bioorganic & medicinal chemistry,
Jun Chang, and Yun-Peng Hao, and Xiao-Dong Hao, and Hong-Fu Lu, and Jian-Ming Yu, and Xun Sun
March 2006, Bioorganic & medicinal chemistry letters,
Jun Chang, and Yun-Peng Hao, and Xiao-Dong Hao, and Hong-Fu Lu, and Jian-Ming Yu, and Xun Sun
September 1995, Journal of medicinal chemistry,
Jun Chang, and Yun-Peng Hao, and Xiao-Dong Hao, and Hong-Fu Lu, and Jian-Ming Yu, and Xun Sun
September 2008, Bioorganic & medicinal chemistry letters,
Jun Chang, and Yun-Peng Hao, and Xiao-Dong Hao, and Hong-Fu Lu, and Jian-Ming Yu, and Xun Sun
May 1997, Journal of medicinal chemistry,
Jun Chang, and Yun-Peng Hao, and Xiao-Dong Hao, and Hong-Fu Lu, and Jian-Ming Yu, and Xun Sun
January 1991, Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie,
Jun Chang, and Yun-Peng Hao, and Xiao-Dong Hao, and Hong-Fu Lu, and Jian-Ming Yu, and Xun Sun
January 2015, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!